Skip to content

Clinical trials

Terminated Myelodysplastic Syndromes trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Terminated Country / region: United Kingdom Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20092
20142
20151
20161
20171
20181
20191
20203
20211
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kiadis Pharma2
King's College Hospital NHS Trust2
Novartis Pharmaceuticals2
Bellicum Pharmaceuticals1
Bristol-Myers Squibb1
Celgene1
Genzyme, a Sanofi Company1
Gilead Sciences1
Inmune Bio, Inc.1
Kyntra Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes19
Leukemia, Myeloid, Acute11
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hematologic Neoplasms3
Leukemia3
Anemia2
Graft vs Host Disease2
Lymphoma, Non-Hodgkin2
Anemia, Aplastic1
Anemia, Diamond-Blackfan1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.